Eli Lilly's Wegovy rival Mounjaro gets UK green light

Mounjaro, Eli Lilly's (NYSE:LLY) rival weightloss drug to Wegovy and Ozempic, is to be made available in the UK after receiving the regulatory green light. The UK Medicines and Healthcare products Regulatory Agency (MHRA) approved a four-dose version of Mounjaro KwikPen to treat adults with type 2 diabetes and for weight management in obese and heavily overweight adults who also have weight-related health problems such as prediabetes, high blood pressure, high cholesterol, or heart problems. The medicine is ...